Result
-€1.7m ▼ 1,090%
The result fell in 2025 from -€141,358 to -€1.7m.
Kom op tegen Kanker
Lifetime
18 annual accounts with figures on one time axis, 20 filings since 2006Turnoverpeak €4.0m (2025)
€4.0m▲ 12.4%
Resultlowest -€9.9m (2016)
-€1.7m▼ €1.5m
Equitypeak €46.7m (2015)
€43.9m▼ 3.7%
Debts
€60.5m▲ 12.0%
Staffpeak 93.1 FTE (2025)
93.1 FTE▲ 3.1%
Board78 names since 1993all names
22 directorsMarc Michils and 21 others
Documentsfilings and deeds
14-04-2026108 days before the deadline
2025abbreviated format
Turnover from €3.6m to €4.0mLoss of €1.7mAppointment: Sara Willems (director) 28-112 directors appointed, 1 resignation 31-07Appointment: Ann Demeulemeester (director) 13-03
Key points
from the 2025 annual accountsStaff
105 employees on 31-12-2025
In 2025, 14 people joined and 7 left. On top of that, 1.4 agency workers worked there on average.
Payment terms
41 days to suppliers
Kom op tegen Kanker pays its suppliers 14 days earlier than in 2024. Customers pay 54 days earlier.
Board
3 joined · 4 left
Board changed. Latest change 11-05-2026 · 21 in office.
Position in the sector
-€1.7m
Lower net result than 95% of companies in membership organisations. Sector median €15,384 · 324 companies.
Public support
€646,823 awarded from 2022 to 2025
Flemish support, mostly Projectsubsidies in het kader van het algemeen welzijnswerk.
Checked score
92
Excellent
Financially stronger than 40% of medium-sized companies in membership organisations (NACE 94)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 75 companies (NACE 94, medium-sized).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025lowest value
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026highest value
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
lowers risk
Legal form: non-profit association
Sector: Activities of membership organisations (NACE 94)
Liquidity: current ratio 5.00, cash €13.5m
Founded in 1989
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 94, medium-sized). It does better than 38% of them on solvency, 61% on liquidity, 10% on profitability and 51% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 830 companies had the same profile as Kom op tegen Kanker has now. Each dot stands for 3 companies, two years later.
96.5%
were still trading
2.9%
stopped another way
0.6%
went bankrupt
That fits the bankruptcy probability of Kom op tegen Kanker itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 830 companies, not a prediction for Kom op tegen Kanker. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €400,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.0 (4.77 in 2024), above the usual 1.5. Short-term debt is 19.5% and cash 12.9% of total assets. However, 57.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-04-2026, 108 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
108 days early
2024
22 days late
2023
113 days early
2022
105 days early
2021
123 days early
2020
110 days early
2019
30 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 81 days before the deadline. In the sector (NACE 94), the median for financial year 2024 was 29 days before the deadline, and 25% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 April (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
CV
Callens, Vandelanotte & Theunissen BV
Auditor, Ann De Ceuster
Recent changes
2 directors appointed, 3 resignations, 2 reappointments
Resignations: Germonpré Siska, De Grève Jacques and Luyten Herta · Appointments: Vuylsteke Peter and Roovers Els · Reappointments: Haustermans Karin and Peeters Marc · General meeting of 31-03-2026 · Gazette deed
Appointment: Sara Willems (director)
Resignation: Ann Van Hecke (director) · General meeting of 15-10-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0442528054
2 directors appointed, 1 resignation
Appointments: Tessa Kerre and Sabien Bauwens · Resignation: Wim Distelmans · General meeting of 27-03-2025 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | Turnover | EBIT margin | Solvency | Staff |
|---|---|---|---|---|
| Kom op tegen Kanker Saint-Josse-ten-Noode | €4.0m | - | 42.1% | 93.1 |
| RAAKZAAM Sint-Niklaas | €2.4m | 24.6% | 40.6% | 192.5 |
| DOKTERS VAN DE WERELD - MEDECINS DU MONDE Saint-Josse-ten-Noode | - | - | 9.1% | 153.9 |
| PREMED, Preventie en Bescherming Leuven | €8.1m | -2.1% | 76.2% | 52.1 |
| DE EUROPESE VERENIGING VOOR HUMANE REPRODUCTIE EN EMBRYOLOGIE Grimbergen | - | - | 97.7% | 23.1 |
| EUROPEAN SOCIETY OF INTENSIVE CARE MEDECINE Brussels | - | - | 44.2% | 9.8 |
| WALLONIE SANTE FINANCES Liège | - | - | 99.6% | 4.5 |
These companies have the same main activity as Kom op tegen Kanker: activities of membership organisations (NACE 94993). They are comparable in size and age: total assets between €12m and €179m, founded between 1966 and 2018.
Official details
Source: KBO- Status
- Active since 03-10-1989Normal situation
- Activity
- Activities of membership organisationsNACE 94993
- Joint committee
- 330Health institutions and services · annual accounts 2025
- Establishment unit
- 2.138.670.1531210 Saint-Josse-ten-Noode, since 30-10-1989
- Financial year end
- 31 December
- Peppol
- Reachable since 11-09-2025
Annual accounts 2025
- Operating revenue
- €44.1m▼ 8.9%
- Total assets
- €104.5m▲ 4.8%
- Employeeson 31-12-2025
- 105▲ 7.1%
- Filing
- Filed on 14-04-2026, 108 days before the end of the filing period
Insights on Kom op tegen Kanker
Kom op tegen Kanker has existed since 1989. The present size dates from 2012. Turnover rose that year from €27,166 to €1.8m.
In May 2026, three directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Kom op tegen Kanker
- What is the company number of Kom op tegen Kanker?
- The company number of Kom op tegen Kanker is 0442.528.054. The VAT number is the same number with BE in front: BE 0442.528.054.
- Where is Kom op tegen Kanker based?
- The registered office is at Koningsstraat 217, 1210 Saint-Josse-ten-Noode.Company details
- What does Kom op tegen Kanker do?
- According to the KBO register, the main activity is activities of membership organisations (NACE 94993).
- What is the legal form of Kom op tegen Kanker?
- Kom op tegen Kanker is a non-profit association (VZW).
- When was Kom op tegen Kanker founded?
- Kom op tegen Kanker was founded on 03-10-1989.
- Is Kom op tegen Kanker still active?
- Yes, Kom op tegen Kanker is an active enterprise in the KBO register.
- How many employees does Kom op tegen Kanker have?
- Kom op tegen Kanker had an average of 93.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Kom op tegen Kanker fall under?
- In its 2025 annual accounts, Kom op tegen Kanker states joint committee 330 (Health institutions and services).
- What is the turnover of Kom op tegen Kanker?
- The turnover of Kom op tegen Kanker was €4.0m in financial year 2025, according to the filed annual accounts.
- Is Kom op tegen Kanker profitable?
- In financial year 2025, Kom op tegen Kanker made a loss of €1.7m.
- Where can I find the annual accounts of Kom op tegen Kanker?
- Kom op tegen Kanker filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Kom op tegen Kanker due?
- Kom op tegen Kanker must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.